Operating Lease, Right-of-Use Asset in USD of LIPELLA PHARMACEUTICALS INC. from Q4 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LIPELLA PHARMACEUTICALS INC. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2021 to Q3 2025.
  • LIPELLA PHARMACEUTICALS INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $263K, a 278% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LIPELLA PHARMACEUTICALS INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $263K +$193K +278% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $275K +$183K +198% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $23.6K -$90.5K -79.3% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $46.8K -$88.4K -65.4% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 $69.6K -$86.9K -55.5% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $92K -$30.6K -24.9% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $114K -$22.8K -16.6% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $135K -$15.7K -10.4% 31 Dec 2023 10-K 28 Mar 2025
Q3 2023 $156K 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $123K 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $137K 31 Mar 2023 10-Q 12 May 2023
Q4 2022 $151K -$54K -26.4% 31 Dec 2022 10-K 27 Feb 2024
Q4 2021 $205K 31 Dec 2021 10-K 31 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.